Parkinson's Disease Therapeutics Pipeline Program
Offers Parkinson's Disease Therapeutics Pipeline Program, supporting teams advancing disease-modifying and symptom-focused Parkinson's treatments toward the clinic.
About
The Parkinson's Disease Therapeutics Pipeline Program sits under the Michael J. Fox Foundation for Parkinson's Research and funds pre-clinical and clinical development for disease-modifying or symptomatic Parkinson's interventions. It also covers biomarker tools that inform therapeutic decisions, so the grant is aimed at development-stage teams rather than early discovery.
Awards run from $250,00…
BiotechMedtechNeurotech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.